Expanding Theranostic Radiopharmaceuticals for Tumor Diagnosis and Therapy.
cam.issuedOnline | 2021-12-22 | |
dc.contributor.author | Barca, Cristina | |
dc.contributor.author | Griessinger, Christoph M | |
dc.contributor.author | Faust, Andreas | |
dc.contributor.author | Depke, Dominic | |
dc.contributor.author | Essler, Markus | |
dc.contributor.author | Windhorst, Albert D | |
dc.contributor.author | Devoogdt, Nick | |
dc.contributor.author | Brindle, Kevin | |
dc.contributor.author | Schäfers, Michael | |
dc.contributor.author | Zinnhardt, Bastian | |
dc.contributor.author | Jacobs, Andreas H | |
dc.contributor.orcid | Barca, Cristina [0000-0001-8034-2948] | |
dc.contributor.orcid | Devoogdt, Nick [0000-0001-9220-4833] | |
dc.contributor.orcid | Brindle, Kevin [0000-0003-3883-6287] | |
dc.contributor.orcid | Zinnhardt, Bastian [0000-0002-8274-9108] | |
dc.date.accessioned | 2022-01-07T16:47:53Z | |
dc.date.available | 2022-01-07T16:47:53Z | |
dc.date.issued | 2021-12-22 | |
dc.date.updated | 2022-01-07T16:47:53Z | |
dc.description.abstract | Radioligand theranostics (RT) in oncology use cancer-type specific biomarkers and molecular imaging (MI), including positron emission tomography (PET), single-photon emission computed tomography (SPECT) and planar scintigraphy, for patient diagnosis, therapy, and personalized management. While the definition of theranostics was initially restricted to a single compound allowing visualization and therapy simultaneously, the concept has been widened with the development of theranostic pairs and the combination of nuclear medicine with different types of cancer therapies. Here, we review the clinical applications of different theranostic radiopharmaceuticals in managing different tumor types (differentiated thyroid, neuroendocrine prostate, and breast cancer) that support the combination of innovative oncological therapies such as gene and cell-based therapies with RT. | |
dc.identifier.doi | 10.17863/CAM.79788 | |
dc.identifier.eissn | 1424-8247 | |
dc.identifier.issn | 1424-8247 | |
dc.identifier.uri | https://www.repository.cam.ac.uk/handle/1810/332342 | |
dc.language | en | |
dc.publisher | MDPI AG | |
dc.subject | theranostics | |
dc.subject | tumor | |
dc.subject | gene therapy | |
dc.subject | cell-based therapy | |
dc.subject | molecular imaging | |
dc.subject | positron emission tomography | |
dc.subject | radiopharmaceuticals | |
dc.title | Expanding Theranostic Radiopharmaceuticals for Tumor Diagnosis and Therapy. | |
dc.type | Article | |
dcterms.dateAccepted | 2021-12-16 | |
prism.issueIdentifier | 1 | |
prism.publicationName | Pharmaceuticals (Basel) | |
prism.volume | 15 | |
pubs.funder-project-id | European Commission Horizon 2020 (H2020) Societal Challenges (831514) | |
rioxxterms.licenseref.uri | https://creativecommons.org/licenses/by/4.0/ | |
rioxxterms.version | VoR | |
rioxxterms.versionofrecord | 10.3390/ph15010013 |
Files
Original bundle
1 - 3 of 3
No Thumbnail Available
- Name:
- pharmaceuticals-15-00013.xml
- Size:
- 12.24 KB
- Format:
- Extensible Markup Language
- Description:
- Bibliographic metadata
- Licence
- https://creativecommons.org/licenses/by/4.0/
No Thumbnail Available
- Name:
- additional-files.zip
- Size:
- 337.34 KB
- Format:
- ZIP file
- Description:
- Supporting information
- Licence
- https://creativecommons.org/licenses/by/4.0/
Loading...
- Name:
- pharmaceuticals-15-00013.pdf
- Size:
- 1.25 MB
- Format:
- Adobe Portable Document Format
- Description:
- Published version
- Licence
- https://creativecommons.org/licenses/by/4.0/